McMaster community welcomes Nancy Baxter as new vice-president and dean for the Faculty of Health Sciences - Faculty of Health Sciences - McMaster University

FUNERAL SERVICE LIVESTREAM LINKGEOFFREY ANDRE BAXTERApril 21, 1947 – October 10, 2026Geoffrey Andre Baxter passed away peacefully on October 10, 2026, at Brampton Civic Hospital, at the age of 79. Born in Calcutta on April 21, 1947—right before the partition of India—Geoff was the cherished youngest of three brothers with a younger sister born to Royal Air Force Sergeant George Alexander Baxter and Iris Marjorie Baxter (Gomes). He grew up grounded in Anglo-Indian history and community, attending St. Patrick's High School in Asansol (1955–1963) and St. James's School in Calcutta, where he earned his First Division Board of Apprenticeship Training qualification in 1964. Though described by his headmaster as 'small in stature,' he proved himself every inch a man on the hockey, cricket, and soccer fields. Geoff built a respected career in industrial and mechanical supervision across India, working with The A. P. V. Engineering Company (1966–1975) rising from apprentice to senior supervisor of pressure vessel and dairy equipment fabrication, followed by roles at Vaidehi Chemicals and Indo Compressed Tools.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.